You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Trump on Cancer-Ridden Biden: ‘I Really Don't Feel Sorry for Him'
- 2. Landscape of targets within nucleoside metabolism for the modification of immune responses
- 3. Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer
- 4. UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer
- 5. ASCO25: Pfizer's Braftovi combo boasts 47% drop in disease progression in mCRC
- 6. Gut bacteria may hold key to unlocking better cancer treatment
- 7. ASCO 2025: Combination of encorafenib and cetuximab with chemotherapy helps some patients with advanced colorectal cancer live longer
- 8. ASCO 2025: First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer
- 9. Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
- 10. ASCO 2025: Risk of fourteen obesity-related cancers for people with diabetes
Last updated at 12:09 GMT
Hot News Makers
Health/Pharma Companies
- 977630.14
- 247182.24
- 30885.47
- 11067.27
- 9929.17
- 9227.91
- 7423.38
- 6792.62
- 6722.87
- 5002.48
Drugs, Treatments, Trials
- 251647.88
- 37840.85
- 17272.17
- 12237.17
- 9522.91
- 7142.18
- 2246.28
- 1269.55
- 1134.84
- 1057.96
Last updated at 11:10 GMT
